A provider rules out allergies and other conditions and may use dietary trials
Biochemical evaluation of Ipamorelin typically involves precise identity verification, purity analysis via high-performance liquid chromatography (HPLC), molecular mass confirmation, and stability assessments under standardized storage conditions
Usage & Safety Information
These assessments were performed in a blinded manner, ensuring the researcher remained unaware of the animals identities and assigned study groups
Tesamorelin is an FDA-approved prescription drug (brand name Egrifta), cleared in 2010 on the strength of multiple Phase 3 double-blind, placebo-controlled randomized trials for a specific, narrow indication: reducing excess abdominal fat in people with HIV-associated lipodystrophy
doi: 10.1016/j.intimp.2023.109790 69 ZhouFMeiJHanXLiHYangSWangMet al